These inhibitor tablets contain broad-spectrum protease inhibitors that are highly effective at preventing proteolytic degradation during cell lysis and protein extraction experiments.

• Formulated without EDTA, a metalloproteinase inhibitor
• Ready-to-use and fully disclosed
• Can be used directly with Pierce BCA assays
• Improved formulation helps the tablets dissolve quickly to form a clear solution
• Do not contain phosphatase inhibitors

Protease inhibitor tablets protect proteins from proteolytic degradation through inhibition of the serine proteases, cysteine proteases, aspartic acid proteases, and aminopeptidases that are typically present in cell lysate samples. The tablets contain AEBSF, aprotinin, bestatin, E-64, leupeptin, and pepstatin A.